- AdventHealth Research Institute
“For me, telesurgery is more than innovation, it’s a humanitarian leap forward. In an era where technology increasingly transcends borders, we hold the power to potentially transform the way health care is delivered to remote, underserved communities that have long lacked access.” – Vipul Patel, MD, Medical Director of the Global Robotics Institute at AdventHealth Celebration
Forging a new medical frontier, Dr. Patel recently performed the longest distance telesurgery ever completed – a robotic prostatectomy on a patient with prostate cancer in Angola, Africa – while operating from the AdventHealth Nicholson Center in Celebration, nearly 7,000 miles away. This achievement was part of his mission to expand access to specialized surgical care for underserved populations in remote and rural locations throughout the world.
Click below to read more about this in our latest Clinician’s View, where Dr. Patel shares his team’s telesurgery journey, including how they are ensuring safety, quality and ethical exploration of this innovative approach:
Recent News
Bringing Cancer Research Into the Home: Dr. Justin Brown's Approach to Trial Design
Justin Brown, PhD, Associate Investigator at AdventHealth, has dedicated his career to studying how exercise can improve outcomes for cancer patients after losing his father to colon cancer as a...
Exercise as “Powerful Medicine”: Spotlight on AdventHealth Research
Recently, Dr. Bret Goodpaster, scientific director of the AdventHealth Translational Research Institute (TRI), appeared on FOX 35 News to discuss groundbreaking research exploring how exercise impacts...
New Study Points to Promising Way to Protect Kidneys in Type 1 Diabetes
Richard E. Pratley, M.D., senior investigator and diabetes program lead at the AdventHealth Translational Research Institute (TRI), served as one of the lead researchers on the international FINE-ONE...
Understanding Hypoglycemia and the CLEAR Study
The CLEAR Study is a groundbreaking, international research effort funded by the NIH that aims to help people with Type 1 diabetes (T1D) who can no longer sense when their blood sugar is dangerously...
Recognizing the Unrecognized: Advancing Research in Childhood Sjögren’s Disease
Sjögren’s disease has been recognized in adults for almost a century, first described by Swedish ophthalmologist Henrik Sjögren in the early 20th century. One of the biggest challenges in recognizing...
Did you know? Women, Hormones, and Heart Risk
Heart disease is often thought of as a “man’s disease,” but it remains the leading cause of death for women in the United States. We asked Katie Love, MD, MSc, an investigator at the AdventHealth...
Weight-Loss Drugs, Hormones, and Midlife: What Women Need to Know
Understanding the connection between GLP-1 medications and hormone therapy
Women, Brain Health, and the Alzheimer’s Puzzle
Why scientists are taking a closer look at why women face higher Alzheimer’s risk
Meet the Team: Dr. Katie Love, MD
Meet Dr. Katie Love an Endocrinologist and Associate Investigator at the AdventHealth Translational Research Institute. Dr. Love was diagnosed with Type 1 diabetes at just four years old and decided...
Clinical Trial Evidence on Diet and Type 1 Diabetes Outcomes
A new systematic review of clinical trials has found that no single dietary pattern consistently improves blood sugar control or weight management in youth and adults living with type 1 diabetes.
How Diet Shapes Gut Microbes and Energy Absorption
What we eat has a big impact on the bacteria living in our gut, which in turn affects how our bodies use energy—something that plays a major role in the development and treatment of obesity.
AdventHealth Neuroscience Institute Launches NIH-Funded THRIVE Trial
AdventHealth Neuroscience Institute has launched THRIVE, an NIH-funded clinical trial led by Lauren Oberlin, PhD, geriatric neuropsychologist and neuroscience researcher.